GGrantIndex
← Leaderboards

Robert H. Getzenberg

University Of Pittsburgh At Pittsburgh

$8,211,645
Attributed
$8,900,019
Total exposure
13
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200513
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$11,145,769 · 14

By mechanism

P50$3,677,378 · 4
U01$2,667,004 · 2
R01$2,266,607 · 3
U54$1,758,969 · 1
P30$500,808 · 1
R13$164,996 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Biomarker

Research focus

BiomarkerHuman TissueLaboratory RatClinical ResearchProstateGene ExpressionBladder NeoplasmHuman SubjectProstate NeoplasmsProgramsBaseElementsMolecularUrinalysisPolymerase Chain ReactionNeoplasm /Cancer DiagnosisDiagnosis Design /EvaluationTranslational ApproachNuclear MatrixGenetic LibraryMolecular CloningDna Binding ProteinPosttranslational ModificationsUrology

Grant awards (44)

MECHANICAL SIGNALING$371,601
U54 · FY2013 · CA · contact PI
MECHANICAL SIGNALING$338,716
U54 · FY2012 · CA · contact PI
Refinement and Discovery of Nuclear Matrix Protein Markers for Colorectal Cancer$655,735
U01 · FY2011 · CA · contact PI
MECHANICAL SIGNALING$333,566
U54 · FY2011 · CA · contact PI
JM-27 as a Potential Biomarker of Symptomatic BPH.$293,191
P50 · FY2011 · DK · contact PI
Administrative Core$174,073
P50 · FY2011 · DK · contact PI
Novel Translational Approaches to BPH/LUTS$38,880
P50 · FY2011 · DK · contact PI
Novel Translational Approaches to BPH/LUTS$1,045,370
P50 · FY2010 · DK · contact PI
Refinement and Discovery of Nuclear Matrix Protein Markers for Colorectal Cancer$721,013
U01 · FY2010 · CA · contact PI
MECHANICAL SIGNALING$363,650
U54 · FY2010 · CA · contact PI
JM-27 as a Potential Biomarker of Symptomatic BPH.$289,555
P50 · FY2010 · DK · contact PI
Administrative Core$174,051
P50 · FY2010 · DK · contact PI
Novel Translational Approaches to BPH/LUTS$32,400
P50 · FY2010 · DK · contact PI
Pilot and Feasibility Program$3
P50 · FY2010 · DK · contact PI
Novel Translational Approaches to BPH/LUTS$1,129,100
P50 · FY2009 · DK · contact PI
MECHANICAL SIGNALING$351,436
U54 · FY2009 · CA · contact PI
JM-27 as a Potential Biomarker of Symptomatic BPH.$311,314
P50 · FY2009 · DK · contact PI
Administrative Core$189,439
P50 · FY2009 · DK · contact PI
Pilot and Feasibility Program$2
P50 · FY2009 · DK · contact PI
Conference--Prouts Neck Prostate Cancer$98,620
R13 · FY2006 · CA · contact PI
Specific Biomarkers in Bladder Cancer Prevention$239,488
R01 · FY2005 · CA
MTOPS Biomarker Unit at the University of Pittsburgh$270,103
U01 · FY2004 · DK
Specific Biomarkers in Bladder Cancer Prevention$217,632
R01 · FY2004 · CA
MTOPS Biomarker Unit at the University of Pittsburgh$173,343
U01 · FY2004 · DK
CHARACTERIZATION OF THE BLADDER CANCER NMP, BLCA-4$162,035
R01 · FY2004 · CA
CHARACTERIZATION OF THE BLADDER CANCER NMP, BLCA-4$67,349
R01 · FY2004 · CA
MTOPS Biomarker Unit at the University of Pittsburgh$423,405
U01 · FY2003 · DK
CHARACTERIZATION OF THE BLADDER CANCER NMP, BLCA-4$230,261
R01 · FY2003 · CA
Specific Biomarkers in Bladder Cancer Prevention$218,365
R01 · FY2003 · CA
Conference--Prouts Neck Prostate Cancer$1
R13 · FY2003 · CA
MTOPS Biomarker Unit at the University of Pittsburgh$423,405
U01 · FY2002 · DK
Prostate and urologic cancer program$250,404
P30 · FY2002 · CA
CHARACTERIZATION OF THE BLADDER CANCER NMP, BLCA-4$231,136
R01 · FY2002 · CA
Conference--Prouts Neck Prostate Cancer$66,375
R13 · FY2002 · CA
Biomarkers of bladder cancer in spinal cord injury individiuals$0
P01 · FY2002 · HD
Prostate and urologic cancer program$250,404
P30 · FY2001 · CA
CHARACTERIZATION OF THE BLADDER CANCER NMP, BLCA-4$231,885
R01 · FY2001 · CA
VITAMIN D EFFECTS ON HUMAHN PROSTATE GROWTH$221,448
R01 · FY2001 · DK
Prostate and urologic cancer program$0
P30 · FY2001 · CA
Biomarkers of bladder cancer in spinal cord injury individiuals$0
P01 · FY2001 · HD
CHARACTERIZATION OF THE BLADDER CANCER NMP, BLCA-4$232,013
R01 · FY2000 · CA
VITAMIN D EFFECTS ON HUMAHN PROSTATE GROWTH$214,995
R01 · FY2000 · DK
PROSTATE CANCER ASSOCIATED NUCLEAR MATRIX ALTERATIONS$110,007
R29 · FY2000 · CA
Prostate and urologic cancer program$0
P30 · FY2000 · CA